ACM
AMPH icon

AUA Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

AUA Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-28
Closed -$785 – 97
2022
Q4 		$785 Sell
28
-13
-32% -$377 ﹤0.01% 315
2022
Q3 		$1K Hold
41
– – ﹤0.01% 290
2022
Q2 		$1K Buy
41
+11
+37% +$393 ﹤0.01% 308
2022
Q1 		$1K Hold
30
– – ﹤0.01% 322
2021
Q4 		$1K Buy
30
+7
+30% +$143 ﹤0.01% 310
2021
Q3 		$0 Sell
23
-8
-26% -$157 ﹤0.01% 346
2021
Q2 		$1K Hold
31
– – ﹤0.01% 297
2021
Q1 		$1K Sell
31
-10
-24% -$186 ﹤0.01% 300
2020
Q4 		$1K Sell
41
-23
-36% -$448 ﹤0.01% 298
2020
Q3 		$1K Buy
+64
New +$1.29K ﹤0.01% 266

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

AUA Capital Management's AMPH Position: Q1 2023 in Review

AUA Capital Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2023, closing a stake of 28 shares — an estimated $785 sold.

AUA Capital Management first reported a position in AMPH in Q3 2020 and held it in 10 quarters. The position peaked at $1K in Q3 2022. 218 funds tracked by Wall St. Rank hold AMPH as of Q1 2023.

  • AUA Capital Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • AUA Capital Management sold 28 Amphastar Pharmaceuticals shares in Q1 2023, an estimated $785.
  • AUA Capital Management first reported a position in Amphastar Pharmaceuticals in Q3 2020 and held it in 10 quarters.
  • AUA Capital Management's Amphastar Pharmaceuticals position peaked at $1K in Q3 2022.
  • 218 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2023.

Based on AUA Capital Management's 13F filing for Q1 2023, filed 20 Apr 2023.